Bayer has entered into an agreement with Resilience Capital Partners and North Park Capital Partners (Resilience/North Park), which will acquire its Multi-Vendor Service (MVS) operations.
MVS provides repair and maintenance, primarily of non-Bayer radiology devices, such as MR coil and ultrasound transducers, as well as CR system and dry film printer services.
According to a statement provided to HCB News by a Bayer spokesperson, this agreement supports the long-term sustainability of MVS in the third-party radiology device repair sector. The company also stated that Resilience/North Park has a proven track record of creating stand-alone companies and will position MVS well for the future.
Resilience Capital Partners and North Park Capital Partners did not immediately return requests for comment.
MVS operates three depot repair centers located in Pittsburgh, PA (MR coil, ultrasound transducer); Tulsa, OK (ultrasound transducer); and Maastricht, the Netherlands (ultrasound transducer), according to its website, and each depot maintains an ISO 13485 certification.
The decision to sell the MVS business aligns with Bayer's focus on its radiology business, which develops, manufactures and markets contrast agents and devices to support successful image acquisition in the radiology suite. Bayer will maintain its service business and will continue to provide service support for the devices it manufactures.
The Bayer MVS business formed as an extension of the Medrad MR coil manufacturing business to repair multi-vendor coils in 1996.
This story may be updated as more information becomes available
